Like many employers, they wanted to know: What is the real impact of GLP-1s on diabetes? Specifically, they want to understand whether the investment in GLP-1s has been effective in a) helping their diabetic population of nearly 3,000 employees and members better manage their chronic disease and b) addressing the $40M+ in annual spend for this population
Tingting Deng, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Adverse drug reactions associated with the use of liraglutide in patients with type 2 diabetesfocus on pancreatitis and pancreas cancer
For more information go to www.P65Warnings.ca.gov.
The clinic matters more than the molecule: sourcing, candidacy screening, and monitoring are what separate responsible care from an online purchase
I Like Taking B12 for My Health and Noticed There Are Different Kinds of B12